Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis von Hauser, Stephen L, Bar-Or, Amit, Comi, Giancarlo, Giovannoni, Gavin, Hartung, Hans-Peter, Hemmer, Bernhard, Lublin, Fred, Montalban, Xavier, Rammohan, Kottil W, Selmaj, Krzysztof, Traboulsee, Anthony, Wolinsky, Jerry S, Arnold, Douglas L, Klingelschmitt, Gaelle, Masterman, Donna, Fontoura, Paulo, Belachew, Shibeshih, Chin, Peter, Mairon, Nicole, Garren, Hideki, Kappos, Ludwig

Volltext

Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) von Langdon, DW, Amato, MP, Boringa, J, Brochet, B, Foley, F, Fredrikson, S, Hämäläinen, P, Hartung, H-P, Krupp, L, Penner, IK, Reder, AT, Benedict, RHB

Volltext

A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS von FREEDMAN, M. S, BAR-OR, A, FERENCZI, L, VERCO, T, OGER, J, TRABOULSEE, A, PATRY, D, YOUNG, C, OLSSON, T, LI, D, HARTUNG, H.-P, KRANTZ, M

Volltext

Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation von Ingwersen, J, Wingerath, B, Graf, J, Lepka, K, Hofrichter, M, Schröter, F, Wedekind, F, Bauer, A, Schrader, J, Hartung, H-P, Prozorovski, T, Aktas, O

Volltext

Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, plac... von Comi, G, Prof, Martinelli, V, MD, Rodegher, M, MD, Moiola, L, MD, Bajenaru, O, Prof, Carra, A, Prof, Elovaara, I, Prof, Fazekas, F, Prof, Hartung, HP, Prof, Hillert, J, Prof, King, J, MD, Komoly, S, Prof, Lubetzki, C, Prof, Montalban, X, Prof, Myhr, KM, Prof, Ravnborg, M, MD, Rieckmann, P, Prof, Wynn, D, MD, Young, C, Prof, Filippi, M, MD

Volltext

Cerebrospinal fluid findings in reversible cerebral vasoconstriction syndrome: a way to differentiate from cerebral vasculitis? von Kraayvanger, L., Berlit, P., Albrecht, P., Hartung, H.‐P., Kraemer, M.

Volltext

Exploiting metabolic acidosis in solid cancers using a tumor-agnostic pH-activatable nanoprobe for fluorescence-guided surgery von Voskuil, F. J., Steinkamp, P. J., Zhao, T., van der Vegt, B., Koller, M., Doff, J. J., Jayalakshmi, Y., Hartung, J. P., Gao, J., Sumer, B. D., Witjes, M. J. H., van Dam, G. M.

Volltext

The Role of Peripheral Myelin Protein 2 in Remyelination von Stettner, Mark, Zenker, Jennifer, Klingler, Fabian, Szepanowski, Fabian, Hartung, Hans-P., Mausberg, Anne K., Kleinschnitz, Christoph, Chrast, Roman, Kieseier, Bernd C.

Volltext

Survey of diagnostic and treatment practices for multiple sclerosis in Europe von Fernández, O., Delvecchio, M., Edan, G., Fredrikson, S., Gionvannoni, G., Hartung, H.‐P., Havrdova, E., Kappos, L., Pozzilli, C., Soerensen, P. S., Tackenberg, B., Vermersch, P., Comi, G.

Volltext

Survey of diagnostic and treatment practices for multiple sclerosis (MS) in Europe. Part 2: Progressive MS, paediatric MS, pregnancy and general management von Fernández, O., Delvecchio, M., Edan, G., Fredrikson, S., Giovannoni, G., Hartung, H.‐P., Havrdova, E., Kappos, L., Pozzilli, C., Soerensen, P. S., Tackenberg, B., Vermersch, P., Comi, G.

Volltext

ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis von Montalban, X., Gold, R., Thompson, A. J., Otero‐Romero, S., Amato, M. P., Chandraratna, D., Clanet, M., Comi, G., Derfuss, T., Fazekas, F., Hartung, H. P., Havrdova, E., Hemmer, B., Kappos, L., Liblau, R., Lubetzki, C., Marcus, E., Miller, D. H., Olsson, T., Pilling, S., Selmaj, K., Siva, A., Sorensen, P. S., Sormani, M. P., Thalheim, C., Wiendl, H., Zipp, F.

Volltext

Safety and efficacy of the selective sphingosine 1-phosphate receptor modulator ozanimod in relapsing multiple sclerosis (RADIANCE): a randomised, placebo-controlled, phase 2 trial von Cohen, Jeffrey A, Dr, Arnold, Douglas L, MD, Comi, Giancarlo, MD, Bar-Or, Amit, MD, Gujrathi, Sheila, MD, Hartung, Jeffrey P, PhD, Cravets, Matt, MA, Olson, Allan, MD, Frohna, Paul A, MD, Selmaj, Krzysztof W, MD

Volltext

Clinical applications of intravenous immunoglobulins (IVIg) – beyond immunodeficiencies and neurology von Hartung, H.‐P., Mouthon, L., Ahmed, R., Jordan, S., Laupland, K. B., Jolles, S.

Volltext

The current standing of autologous haematopoietic stem cell transplantation for the treatment of multiple sclerosis von Willison, A. G., Ruck, T., Lenz, G., Hartung, H. P., Meuth, S. G.

Volltext

Vigorimeter grip strength in CIDP: a responsive tool that rapidly measures the effect of IVIG - the ICE study von Vanhoutte, E. K., Latov, N., Deng, C., Hanna, K., Hughes, R. A. C., Bril, V., Dalakas, M. C., Donofrio, P., van Doorn, P. A., Hartung, H.-P., Merkies, I. S. J.

Volltext

Requirement for safety monitoring for approved multiple sclerosis therapies: an overview von Rommer, P. S., Zettl, U. K., Kieseier, B., Hartung, H.‐P., Menge, T., Frohman, E., Greenberg, B. M., Hemmer, B., Stüve, O.

Volltext

Degeneration of retinal layers in multiple sclerosis subtypes quantified by optical coherence tomography von Albrecht, P, Ringelstein, M, Müller, AK, Keser, N, Dietlein, T, Lappas, A, Foerster, A, Hartung, HP, Aktas, O, Methner, A

Volltext

Patient‐reported outcomes with subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy: the PATH study von Hartung, H.‐P., Mallick, R., Bril, V., Lewis, R. A., Sobue, G., Lawo, J.‐P., Mielke, O., Durn, B. L., Cornblath, D. R., Merkies, I. S. J., van Schaik, I. N.

Volltext

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes von KAPPOS, L, POLMAN, C. H, POHL, C, SANDBRINK, R, FREEDMAN, M. S, EDAN, G, HARTUNG, H. P, MILLER, D. H, MONTALBAN, X, BARKHOF, F, BAUER, L, JAKOBS, P

Volltext

Magnetic resonance angiography: current status and future directions von Hartung, Michael P, Grist, Thomas M, François, Christopher J

Volltext